Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulopenem in Hospitalized CAP
NCT00797108Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2009
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of sulopenem in community acquired pneumonia (CAP), sponsored by Pfizer. Started Jan 2009; status: completed.
02
Drugs
sulopenem
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00797108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797108.